THE REQUIREMENTS FOR ADDITIONAL STRENGTH BIOWAIVERS FOR IMMEDIATE RELEASE SOLID ORAL DOSAGE FORMS IN INTERNATIONAL PHARMACEUTICAL REGULATORS PROGRAMME PARTICIPATING REGULATORS AND ORGANISATIONS: DIFFERENCES AND COMMONALITIES

The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities

In relation to the registration of generic products, waivers of in vivo bioequivalence studies (biowaivers) are considered in three main cases: certain dosage forms for which bioequivalence is self-evident (e.g.intravenous solutions), biowaivers based on the Biopharmaceutics Hand cream Classification System and biowaivers for additional strengths w

read more



Automatic generation of pseudoknotted RNAs taxonomy

Abstract Background The ability to compare RNA secondary structures is important in understanding their biological function and for grouping Tape similar organisms into families by looking at evolutionarily conserved sequences such as 16S rRNA.Most comparison methods and benchmarks in the literature focus on pseudoknot-free structures due to the di

read more